|
Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly
|
25 September 2015 |
|
Advances in meningioma therapy
|
24 September 2015 |
|
Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line
|
23 September 2015 |
|
Vitamin D intake and the risk for pancreatic cancer in two cohort studies
|
22 September 2015 |
|
Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion
|
21 September 2015 |
|
A unique cytoplasmic localization of retinoic acid receptor-gamma and its regulations
|
21 September 2015 |
|
A phase II study of anastrozole plus the pineal anticancer hormone melatonin in the metastatic breast cancer women with poor clinical status
|
18 September 2015 |
|
Physiological and metabolic functions of melatonin
|
18 September 2015 |
|
A review of the multiple actions of melatonin on the immune system
|
17 September 2015 |
|
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study
|
16 September 2015 |